Bill Text: GA SB378 | 2011-2012 | Regular Session | Engrossed
Bill Title: Controlled Substances; changes to definition of written prescriptions for dangerous drugs; revise a definition
Spectrum: Moderate Partisan Bill (Republican 4-1)
Status: (Engrossed - Dead) 2012-02-27 - House Second Readers [SB378 Detail]
Download: Georgia-2011-SB378-Engrossed.html
12 LC
37 1389S (SCS)
Senate
Bill 378
By:
Senators Carter of the 1st, Williams of the 19th, McKoon of the 29th, Bethel of
the 54th and Jackson of the 2nd
AS
PASSED SENATE
A
BILL TO BE ENTITLED
AN ACT
AN ACT
To
amend Chapter 13 of Title 16 of the Official Code of Georgia Annotated, relating
to controlled substances, so as to revise a definition; to provide for certain
changes to the definition of written prescriptions for dangerous drugs; to add
to provisions concerning unlawful offering or selling of certain drugs; to
provide for increase of penalties for violation of certain laws; to provide for
related matters; to repeal conflicting laws; and for other
purposes.
BE
IT ENACTED BY THE GENERAL ASSEMBLY OF GEORGIA:
SECTION
1.
Chapter
13 of Title 16 of the Official Code of Georgia Annotated, relating to controlled
substances, is amended by revising paragraph (23) of Code Section 16-13-21,
relating to definitions, as follows:
"(23)
'Practitioner' means:
(A)
A physician, dentist, pharmacist, podiatrist, scientific investigator,
veterinarian,
or other person licensed, registered, or otherwise authorized under the laws of
this state or
any other state or territory in the United
States to distribute, dispense, conduct
research with respect to, or
to
administer a controlled substance in the course of professional practice or
research in this state;
(B)
A pharmacy, hospital, or other institution licensed, registered, or otherwise
authorized by law to distribute, dispense, conduct research with respect to, or
to
administer a controlled substance in the course of professional practice or
research in this state;
(C)
An advanced practice registered nurse acting pursuant to the authority of Code
Section 43-34-25. For purposes of this chapter and Code Section 43-34-25, an
advanced practice registered nurse is authorized to register with the federal
Drug Enforcement Administration and appropriate state authorities;
or
(D)
A physician assistant acting pursuant to the authority of subsection (e.1) of
Code Section 43-34-103. For purposes of this chapter and subsection (e.1) of
Code Section 43-34-103, a physician assistant is authorized to register
with the federal Drug Enforcement Administration and appropriate state
authorities."
SECTION
2.
Said
chapter is further amended by revising Code Section 16-13-74, relating to
written prescriptions for dangerous drugs, content, and signature, as
follows:
"16-13-74.
(a)
All written prescription drug orders for dangerous drugs
and controlled
substances shall be dated as of, and be
signed on, the date when issued and shall bear the name and address of the
patient, together with the name and strength of the drug, the quantity to be
dispensed, complete directions for administration, the printed name, address,
and telephone number of the practitioner, and the number of permitted refills. A
prescription drug order for a dangerous drug is not required to bear the DEA
permit number of the prescribing practitioner. A prescription drug order for a
dangerous drug
or controlled
substance may be prepared by the
practitioner or the practitioner's agent. The practitioner's signature must
appear on each prescription prepared by the practitioner or the practitioner's
agent and the nature of the practitioner's signature must meet the guidelines
set forth in Chapter 4 of Title 26, the regulations promulgated by the
State Board of Pharmacy, or both such guidelines and regulations. Any
practitioner who shall dispense dangerous drugs
or controlled
substances shall comply with the
provisions of Code Section 16-13-73.
This
subsection shall not apply to prescription drug orders written for and
administered to hospital patients.
(b)
Any practitioner of the healing arts who fails to comply with subsection (a) of
this Code section shall be guilty of a misdemeanor."
SECTION
3.
Said
chapter is further amended by revising Code Section 16-13-78.2, relating to
possession, manufacture, delivery, distribution, or sale of counterfeit
substances, as follows:
"16-13-78.2.
(a)
Except as authorized by this article, it is unlawful for any person to possess,
have under his
or
her control, manufacture, deliver,
distribute, dispense, administer, sell,
offer or
attempt to sell, or possess with intent to
distribute a
drug that is marked as a drug sample, adulterated, or
misbranded; or
a
counterfeit substance
as defined by
Code Section 16-13-21 or under the provisions of the Federal Food, Drug, and
Cosmetic Act. Any person who violates
this Code section shall be guilty of a
misdemeanor
felony and
upon conviction thereof shall be punished by not less than five years
imprisonment or by a fine not to exceed $100,000.00 or
both.
(b)
This Code section shall not apply to drug samples lawfully possessed by any
practitioner or facility for distribution or dispensing to patients at no
cost."
SECTION
4.
All
laws and parts of laws in conflict with this Act are repealed.